This statement summarizes the U Pre...

This statement summarizes the U Preventive Services Task Force (USPSTF) recommendations upon screening for developmental dysplasia of the hip (DDH) and the supporting scientific evidence. Explanations of the ratings and of the vigor of overall evidence are given in Table 1 and Table 2 respectively. The completed information on which this statement is based, including evidence tables and intimations is included in the systemic literature review (1) and evidence synthesis (2) upon this topic, which is available forward the USPSTF Web site at http://www.preventiveservices. ahrq.gov. The recommendation also is pillared on the Web site of the National Guideline Clearinghouse at http://www.guideline.gov.

Summary of Recommendations

The USPSTF determines that evidence is insufficient to commend routine screening for DDH in infants as a means to hinder adverse outcomes. I recommendation.

The pathophysiology and natural history of DDH are poorly understood. There is evidence that screening leads to earlier identification; however, 60 to 80 percent of the hips of newborns identified as abnormal or as suspicious for DDH by dint of physical examination and more than 90 percent of those identified according to ultrasonography in the newborn period decipher spontaneously, requiring no intervention. There is poor evidence (poor-quality studies) of the effectiveness of as well-as; not only-but also; not only-but; not alone-but surgical and non-surgical interventions; avascular necrosis of the hip (AVN) is reported in 0 to 60 percent of children who are treated for DDH Thus, the USPSTF was unable to assess the balance of benefits and harms of screening for DDH moreover was concerned about the potential harms associated with treatment of infants identified by the agency of routine screening.

Clinical Considerations

* This USPSTF screening recommendation applies solitary to infants who do not have obvious hip dislocations or other abnormalities evident without screening. DDH exhibits a spectrum of anatomic abnormalities in which the femoral head and the acetabulum are aligned improperly or become greater [i]or[/i] larger abnormally. DDH can lead to premature degenerative joint disease, impaired walking, and pain. Risk factors for DDH include female sex family history of DDH after part positioning, and in utero postural deformities. However, mostly infants with DDH have no identifiable risk factors.

* Screening touchstones for DDH have limited accuracy. The greatest in quantity common methods of screening are serial physical examinations of the hip and lower extremities using the Barlow and Ortolani deeds and ultrasonography. The Barlow examination is performed by the agency of adducting a flexed hip with indulgent posterior force to identify a dislocatable hip. The Ortolani examination is performed according to abducting a flexed hip with gentle-hearted anterior force to relocate a dislocated hip. Data assessing the relative value of limited hip abduction as a screening tool are sparse and recommend the test is of little value in early infancy and is of somewhat greater value as infants age.

* Treatments for DDH include as well-as; not only-but also; not only-but; not alone-but nonsurgical and surgical options. Nonsurgical treatment with abduction devices is used in early treatment and includes the commonly prescribed Pavlik system Surgical intervention is used when DDH is chaste or diagnosed late or after an futile trial of nonsurgical treatments. Evidence of the effectiveness of interventions is inconclusive because of a high rate of spontaneous resolution, absence of comparative studies of intervention versus nonintervention assign places tos and variations in surgical indications and protocols. Avascular necrosis of the hip is the mostly common and most severe potential harm of the pair surgical and nonsurgical interventions and can spring in growth arrest of the hip and eventual joint destruction with significant disability.

Discussion

DDH shows a spectrum of anatomic abnormalities in which the femoral head and the acetabulum are in improper alignment or vegetate abnormally. Without the normal tight, concentric anatomic relationship between the femoral head and acetabulum, the hip joint may vegetate abnormally, resulting in permanent disability. The precise definition of DDH is controversial (34) and includes a image of hip abnormalities, including dysplastic, subluxated, dislocatable, and dislocated hips. Long-term complications of DDH include premature degenerative joint disease, impaired walking, and chronic pain. (5) The incidence of DDH in infants is influenced by way of a number of factors, including diagnostic criteria, female sex genetics, race, and age. (6) Reported incidence rates, varying between 15 and 20 for 1,000 births, (7) have increased dramatically since the advent of clinical and sonographic screening, possibly resulting from overdiagnosis. A minority (10 to 27 percent) of all infants diagnosed with DDH in population-based studies have identified risk factors other than female sex (8-12) Between 1 and 10 percent of infants with risk factors have DDH (9-11)

The USPSTF examined the evidence to determine the benefits and harms of routine screening for DDH from birth within six months and for interventions up to 12 month in otherwise normal infants. The USPSTF construct no direct evidence that screening for DDH leads to a reduc ne for surgery or improved functional issues Therefore, the USPSTF examined the evidence for accuracy of screening tools, effectiveness of treatment, and harms of screening and treatment.